Why Amylyx is pulling ALS drug Relyvrio from US market after study
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
Related articles
Georgia Republicans choose Amy Kremer, organizer of pro
COLUMBUS, Ga. (AP) — Georgia Republicans on Saturday elected to the Republican National Committee a2024-05-21Churchill Downs unveils new $200 million paddock ahead of the 150th Kentucky Derby
LOUISVILLE, Ky. (AP) — Finished just in time for the 150th Kentucky Derby is Churchill Downs’ latest2024-05-21Rita Ora shows off her glamorous sense of style in a black cape as she steps out in New York
Rita Ora showed off her glamorous sense of style in a black cape as she stepped out in New York on T2024-05-21The Fed indicated rates will remain higher for longer. What does that mean for you?
NEW YORK (AP) — Mortgage rates, credit card rates, auto loan rates, and business loans with variable2024-05-21Russian theater director and playwright go on trial over a play authorities say justifies terrorism
TALLINN, Estonia (AP) — A Russian court on Monday opened the trial of a theater director and a playw2024-05-21F1 paddock watches to see if Verstappen leaves Red Bull with car builder or if Hamilton lands Newey
MIAMI GARDENS, Fla. (AP) — The jostling for superstar technical director Adrian Newey was rampant th2024-05-21
atest comment